This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Quest Diagnostics Investments, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Frederic M Waldman: Innovator in Thyroid Cancer Screening
Introduction
Frederic M Waldman is an accomplished inventor based in the United States. He has made significant contributions to the field of medical technology, particularly in the area of thyroid cancer diagnostics. His work focuses on improving patient outcomes through innovative screening methods.
Latest Patents
Waldman's notable patent is titled "Compositions And Methods For Screening Mutations In Thyroid Cancer." This technology relates to methods for determining whether a patient with thyroid nodules and indeterminate cytology will benefit from diagnostic surgery, such as lobectomy. The methods are based on screening a patient's thyroid nodules and detecting alterations in target nucleic acid sequences corresponding to a specific set of thyroid cancer-related genes. Additionally, kits for practicing these methods are provided.
Career Highlights
Throughout his career, Waldman has focused on advancing medical diagnostics. His innovative approaches aim to enhance the accuracy of thyroid cancer detection, ultimately leading to better treatment decisions for patients. His work is characterized by a commitment to improving healthcare outcomes through scientific research and technological advancements.
Collaborations
Waldman has collaborated with Shih-Min Cheng, contributing to the development of his patent and enhancing the research efforts in the field of thyroid cancer diagnostics.
Conclusion
Frederic M Waldman is a notable inventor whose work in thyroid cancer screening exemplifies the intersection of innovation and healthcare. His contributions have the potential to significantly impact patient care and treatment strategies.